Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jacobi

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Ophthalmology|February 13, 2001
Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: A randomized clinical trialC Jonescu-Cuypers, P Jacobi, W Konen, et al.
Der Nervenarzt|March 1, 1973
[Longtime study on the effects of L-dopa therapy in parkinsonism]P A Fischer, E Schneider, P Jacobi, et al.
Lipids|January 1, 1972
The effects of biliary obstruction on the rates of uptake, synthesis and secretion of 14 C-labeled cholesterol by isolated perfused rat liversR M Ferris, H P Jacobi, A J Barak
Physiological Chemistry and Physics|January 1, 1973
Some effects of vitamin E deficiency on in vitro cholesterol metabolismC D Eskelson, H P Jacobi, D M Fitch
Arzneimittel-Forschung|January 1, 1978
[The influence of MIF (melanocyte-stimulating hormone-release inhibiting factor) on psychomotor function and mood in parkinsonian patients. Preliminary report (author's transl)]E Schneider, P A Fischer, P Jacobi, et al.
Der Nervenarzt|November 1, 1974
[Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa]P Jacobi, E Schneider, W Gundelsheimer, et al.
Virology|December 1, 1975
Fingerprint analyses of cytoplasmic adenovirus 2 RNA size classes synthesized late in productive infectionJ Tal, P Jacobi, H J Raskas, et al.
Fortschritte Der Neurologie-Psychiatrie|May 1, 1981
[Mortality in Parkinson's disease and its modification by levodopa (author's transl)]E Schneider, P A Fischer, P Jacobi, et al.
Fortschritte Der Neurologie-Psychiatrie|June 1, 1984
[Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions]E Schneider, P A Fischer, P Jacobi, et al.
Die Medizinische Welt|November 9, 1973
[Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor]P A Fischer, E Schneider, P Jacobi, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Ophthalmology|February 13, 2001
Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: A randomized clinical trialC Jonescu-Cuypers, P Jacobi, W Konen, et al.
Der Nervenarzt|March 1, 1973
[Longtime study on the effects of L-dopa therapy in parkinsonism]P A Fischer, E Schneider, P Jacobi, et al.
Lipids|January 1, 1972
The effects of biliary obstruction on the rates of uptake, synthesis and secretion of 14 C-labeled cholesterol by isolated perfused rat liversR M Ferris, H P Jacobi, A J Barak
Physiological Chemistry and Physics|January 1, 1973
Some effects of vitamin E deficiency on in vitro cholesterol metabolismC D Eskelson, H P Jacobi, D M Fitch
Arzneimittel-Forschung|January 1, 1978
[The influence of MIF (melanocyte-stimulating hormone-release inhibiting factor) on psychomotor function and mood in parkinsonian patients. Preliminary report (author's transl)]E Schneider, P A Fischer, P Jacobi, et al.
Der Nervenarzt|November 1, 1974
[Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa]P Jacobi, E Schneider, W Gundelsheimer, et al.
Virology|December 1, 1975
Fingerprint analyses of cytoplasmic adenovirus 2 RNA size classes synthesized late in productive infectionJ Tal, P Jacobi, H J Raskas, et al.
Fortschritte Der Neurologie-Psychiatrie|May 1, 1981
[Mortality in Parkinson's disease and its modification by levodopa (author's transl)]E Schneider, P A Fischer, P Jacobi, et al.
Fortschritte Der Neurologie-Psychiatrie|June 1, 1984
[Exogenous psychoses in Parkinson syndrome. Frequency and causal conditions]E Schneider, P A Fischer, P Jacobi, et al.
Die Medizinische Welt|November 9, 1973
[Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor]P A Fischer, E Schneider, P Jacobi, et al.
Pageof 8